CurrentEndo
Get Weekly

CurrentEndo coverage · page 26 of 55

Diabetes, Obesity and Metabolism

Briefs 1,001–1,040 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Short‐term associations between metabolic heterogeneity of obesity and cognitive frailty transitions: An ongoing Chinese elderly cohort study

    Cohort studyObesity

  2. Diabetes Obes Metab

    First‐in‐human study of HDM1002 , a GLP ‐1 receptor agonist: Safety, tolerability, pharmacokinetics and pharmacodynamics of escalating single oral doses in healthy volunteers

    Randomized controlled trialT2D & other

  3. Diabetes Obes Metab

    Changes in adiposity indices over 10 years and risk of type 2 diabetes: The Whitehall II cohort study

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Association of device measured physical activity with liver fat and stiffness in people with type 1 diabetes

    Cross-sectional studyT1D

  5. Diabetes Obes Metab

    Differential effects of a multidomain intervention on cognitive decline in older adults with type 2 diabetes according to white matter hyperintensity status: A secondary analysis of the J‐ MIND ‐Diabetes

    Secondary analysisT2D & other

  6. Diabetes Obes Metab

    Persisting plasma proinsulin levels in a cohort of 482 individuals with long‐standing type 1 diabetes mellitus

    Cross-sectional studyT1D

  7. Diabetes Obes Metab

    Body roundness index ( BRI ) and obesity‐related anthropometrics: Relationship to visceral adiposity, insulin sensitivity index and cardiometabolic risk

    Cross-sectional studyObesity

  8. Diabetes Obes Metab

    Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care

    Diagnostic or prognostic studyT2D & other

  9. Diabetes Obes Metab

    Association between recent real‐life exposure to hypoglycaemia and cognitive function during hypoglycaemia in people with type 1 diabetes: Findings from the Hypo‐ RESOLVE clamp study

    Mechanistic studyT1D

  10. Diabetes Obes Metab

    Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents

    Meta-analysisObesity

  11. Diabetes Obes Metab

    Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity

    Cohort studyObesity

  12. Diabetes Obes Metab

    Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed‐loop system (Omnipod® 5) in adults with type 1 diabetes

    Cohort studyTechnology

  13. Diabetes Obes Metab

    Cardiovascular autonomic dysfunction precedes cardiovascular disease and all‐cause mortality: 11‐year follow‐up in the ADDITION ‐ PRO study

    Cohort study

  14. Diabetes Obes Metab

    Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts

    Cohort studyComplications

  15. Diabetes Obes Metab

    Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting

    Cohort studyTechnology

  16. Diabetes Obes Metab

    Exploring population and sex‐specific disease trajectories for multimorbidities among individuals with overweight or obesity: A retrospective cohort study in UK biobank

    Cohort studyObesity

  17. Diabetes Obes Metab

    Cost‐effectiveness analysis of four glucagon‐like peptide‐1 or glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonists for the treatment of adult patients with overweight and obesity in China

    Meta-analysisObesity

  18. Diabetes Obes Metab

    Perioperative use and accuracy of continuous glucose monitoring: A systematic review

    Meta-analysisTechnology

  19. Diabetes Obes Metab

    The cost‐utility and budget impact analyses of Tirzepatide versus once‐weekly Semaglutide as add‐on therapy to metformin in patients with type 2 diabetes mellitus in China

    Cohort studyT2D & other

  20. Diabetes Obes Metab

    Long‐term preservation of kidney function with SGLT ‐2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease

    Cohort studyComplications

  21. Diabetes Obes Metab

    Cardiometabolic risk effects of weight‐loss medications: An updated network meta‐analysis

    Meta-analysisObesity

  22. Diabetes Obes Metab

    Multi‐modal models using fMRI , urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease

    Diagnostic or prognostic studyComplications

  23. Diabetes Obes Metab

    Genomic risk prediction for type 2 diabetes in Australian individuals aged 70 years and older

    Cohort studyT2D & other

  24. Diabetes Obes Metab

    A personalized approach to classify the degree of liver insulin resistance in children with obesity

    Research articleObesity

  25. Diabetes Obes Metab

    A study on the utilization of canagliflozin in type 1 diabetes mellitus using real‐world data from four European countries

    Cohort studyT1D

  26. Diabetes Obes Metab

    Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank

    Cohort studyObesity

  27. Diabetes Obes Metab

    Sex‐ and age‐specific determinants of diabetes: Insights from BKMR and cox modelling of metabolic and lifestyle risk factors in a Korean cohort

    Cohort studyT2D & other

  28. Diabetes Obes Metab

    Long‐term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real‐world setting in Finnish paediatric and adult individuals with type 1 diabetes

    Research articleTechnology

  29. Diabetes Obes Metab

    Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: A meta‐analysis and meta‐regression of 44 randomized controlled trials

    Meta-analysisT2D & other

  30. Diabetes Obes Metab

    Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY ‐ CVR study

    Secondary analysisT2D & other

  31. Diabetes Obes Metab

    Efficacy and safety of PEGylated uricase in healthy adults and patients with hyperuricaemia: A phase I, randomized, double‐blind, dose‐escalation, placebo‐controlled trial

    Randomized controlled trial

  32. Diabetes Obes Metab

    Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: A systematic review

    Meta-analysisT1D

  33. Diabetes Obes Metab

    Alterations in the functional MRI ‐based temporal brain organisation in individuals with obesity

    Cross-sectional studyObesity

  34. Diabetes Obes Metab

    Characteristics of changes in bone mineral density and body composition in obesity patients after metabolic and bariatric surgery: A prospective cohort study

    Cohort studyObesity

  35. Diabetes Obes Metab

    Glycaemic impact of the pre‐exercise timing of an elevated glucose target implemented using an automated insulin delivery system in adults with type 1 diabetes

    Randomized controlled trialTechnology

  36. Diabetes Obes Metab

    Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis

    Meta-analysisLipids & liver

  37. Diabetes Obes Metab

    Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada

    Cohort studyT1D

  38. Diabetes Obes Metab

    Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months

    Cohort study

  39. Diabetes Obes Metab

    PIONEER REAL Spain : A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes

    Cohort studyT2D & other

  40. Diabetes Obes Metab

    Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation

    Meta-analysisT2D & other

All 2,200 Briefs in ExploreShowing Briefs 1,001–1,040 of 2,200, newest first